Islet transplantation in diabetic rats receiving corticosteroids

Area of Science:

• Endocrinology
• Transplantation Immunology
• Metabolic Diseases

Background:

• Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
• Pancreatic islet transplantation is a potential therapeutic strategy for type 1 diabetes.
• Immunosuppression is crucial for the long-term survival of transplanted islets.

Purpose of the Study:

• To evaluate the efficacy of pancreatic islet transplantation in reversing diabetes in rats.
• To assess the function of transplanted islets under immunosuppressive corticosteroid therapy.
• To determine the impact of islet transplantation on glucose homeostasis and insulin secretion.

Main Methods:

• Neonatal Lewis rat pancreatic islet fragments were transplanted into the peritoneal cavities of isologous diabetic rats.
• Recipients received prednisolone, a corticosteroid immunosuppressant, on a clinically relevant schedule.
• Plasma glucose and insulin levels were monitored, and intravenous glucose tolerance tests (IVGTTs) were performed.

Main Results:

• Six of seven diabetic rats receiving islet transplants and prednisolone showed normalized plasma glucose levels within 3 weeks.
• Insulin levels in successful transplant recipients normalized and remained within the normal range, with steady weight gain.
• IVGTTs demonstrated that transplanted islets responded rapidly to glucose challenges, maintaining normal glucose levels despite lower overall insulin levels compared to controls.

Conclusions:

• Peritoneal islet transplantation combined with chronic corticosteroid immunosuppression can effectively reverse diabetes in rats.
• Implanted islet tissue demonstrates functional capacity, releasing sufficient insulin to normalize glucose under both basal and stimulated conditions.
• This study highlights the potential of islet transplantation as a viable treatment for diabetes, even in the presence of immunosuppressive therapy.